Skip to main content
logo
The Gorman-Rupp Company (GRC)
NYSE: GRC · Real-Time Price · USD
41.88
+1.03 (2.52%)
Aug 4, 2025, 4:00 PM - Market closed

Blueprint Medicines Revenue

The Gorman-Rupp Company had revenue of $179.05M in the quarter ending June 30, 2025, with 5.62% growth. This brings the company's revenue in the last twelve months to $673.88M, up 2.60% year-over-year. In the year 2024, The Gorman-Rupp Company had annual revenue of $659.67M with 0.02% growth.

Revenue (ttm)
$673.88M
Revenue Growth
+2.60%
P/S Ratio
1.63
Revenue / Employee
$464,745
Employees
1,450
Market Cap
1.10B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024659.67M156.00K0.02%
Dec 31, 2023659.51M138.48M26.58%
Dec 31, 2022521.03M142.71M37.72%
Dec 31, 2021378.32M29.35M8.41%
Dec 31, 2020348.97M-49.21M-12.36%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
RTX Corporation83.60B
The Boeing Company75.33B
Lockheed Martin71.84B
Caterpillar63.26B
Deere & Company45.38B
General Electric Company41.61B
Honeywell International39.99B
GE Vernova36.62B
Revenue Rankings

GRC News

More News